Researchers at the University of Illinois at Chicago reported that combining activated charcoal with herpes treatment acyclovir, improves the drug’s efficacy.
Seres Therapeutics draws distinction between its quality practices and those of the fecal microbiota for transplantation (FMT) operations that triggered FDA alert.
As the death toll from MERS in South Korea edged to two dozen scientists there say the outbreak is different from in Saudi Arabia and also from its the related virus SARS.
‘Smart’ syringes that can’t be reused should be the drug and vaccine delivery technology of choice for healthcare programmes according to the WHO, which says needle reuse is spreading deadly infectious diseases.
The worst Ebola virus outbreak in history continues to spread in West Africa as biopharma companies are hampered by funding issues in trying to bring treatments and vaccines to human trials, a scientist says.
Evotec has acquired all shares in UK-based specialist CRO Euprotec for as much as $5.26m to add anti-infective drug discovery services to its offerings.
Polypid says a new version of its lipid-polymer fusion-based technology has shown promise for the delivery of antibiotic in the treatment of bone fractures.
AstraZeneca (AZ) has continued its pipeline consolidation by
investing a further $100m (€77m) in its Boston research centre,
which focuses on treatments for infectious diseases and cancer.
Researchers in the UK think that knowledge of 'movement routes' is
the key to predicting patterns of spread of infectious diseases in
humans, which would enable scientists to administer effective drug
therapies that are...
Graffinity, announced today that it has entered into its second
research collaboration with Mutabilis, which aims to discover novel
therapeutics for infectious diseases, building on 2003's
collaboration focusing on another anti-infective...
Scientists have demonstrated that a mouse virus that causes mammary
cancer can infect human cells. This latest study attempts to shed
light on a debate stretching back to the early 70's, which show
that a viral-like agent may...